DGAP-Adhoc: Deutsche Beteiligungs AG: Dividend of 1.20

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Nov 28, 2013 at 8:30 AM

DGAP-Adhoc: Deutsche Beteiligungs AG: Dividend of 1.20 euros per share recommended again

Deutsche Beteiligungs AG / Key word(s): Dividend/Final Results 28.11.2013 14:19 Dissemination of an Ad hoc announcement according to Â§ 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Announcement consistent with Â§ 15 WpHG Deutsche Beteiligungs AG, WKN A1TNUT DBAG: Dividend of 1.20 euros per share recommended again Net income for 2012/2013 totals a preliminary 32.2 million euros The Board of Management and the Supervisory Board of Deutsche Beteiligungs AG announced that, at the Annual Meeting of Shareholders, they will again recommend paying a dividend of 1.20 euros per share, consisting of a base dividend of 0.40 euros per share in addition to a surplus dividend of 0.80 euros per share. A resolution on that proposal was passed today. In the preceding year, the Company also paid a total dividend of 1.20 euros per share (including a base dividend of 0.40 euros per share). The dividend is in keeping with the policy that Deutsche Beteiligungs AG has been pursuing in recent years: in addition to a base dividend, a surplus dividend is to be paid in years recording an appropriate capital gain on divestments. The proposed surplus dividend this year derives -like the surplus dividend last year - from the sale of the Company's investment in Coperion in November 2012. The gain realised led to a sizeable retained profit in financial year 2012/2013 for Deutsche Beteiligungs AG based on the German GAAP format ('HGB'). The tentative consolidated net income (IFRS) of Deutsche Beteiligungs AG for the 2012/2013 financial year (1 November to 31 October) totals 32.2 million euros. The gain largely stems from unrealised value movements; a major contribution came from the rise in the stock market price of Homag shares, the largest investment in the portfolio. Comprehensive income amounts to a preliminary 28.6 million euros. In the preceding 2011/2012 financial year, the Company posted consolidated net income of 44.5 million euros and comprehensive income of 38.3 million euros; the prior year saw one-off effects of approximately ten million euros that had a positive impact on income. Net asset value per share increased from 19.46 euros at the beginning of financial year 2012/2013 to a preliminary 20.35 euros per share at the end of the period. Adjusted for the cash dividend of 0.40 euros per share in addition to a surplus dividend of 0.80 euros per share paid in March 2013, the tentative return on net asset value per share for 2012/2013 equates to 11.4 percent. For the preceding year, the return on net asset value per share was 16.7 percent. The complete Annual Report is scheduled to be published on 28 January 2014. The Board of Management Frankfurt am Main, 28 November 2013 28.11.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Deutsche Beteiligungs AG BÃ¶rsenstrasse 1 60313 Frankfurt am Main Germany Phone: +49 (0)69 957 87-01 Fax: +49 (0)69 957 87-199 E-mail: welcome@deutsche-beteiligung.de Internet: www.deutsche-beteiligung.de ISIN: DE000A1TNUT7 WKN: A1TNUT Indices: SDAX Listed: Regulierter Markt in DÃ¼sseldorf, Frankfurt (Prime Standard); Freiverkehr in Berlin, Hamburg, MÃ¼nchen, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moore Law Urges Millrose Investors: Join the Action

Is Millrose Playing a Risky Game? When I caught wind of this latest debacle with Millrose Properties, Inc. (NYSE: MRP), my gut reaction was a mix of curiosity and skepticism. Hunterbrook Media's report just blasted across the headlines, digging up some dirt on Millrose's recent financial maneuvers. Apparently, these cats have been busy buying homes to the tune of $200...

TilePix Expands into Walmart with Nail-Free Decor Launch

TilePix Makes Big Moves with Walmart TilePix is launching their new line of nail-free wall décor at Walmart—this ain’t your grandma’s wall art. This company's bringing their magnetic, nail-free wizardry to retail stores nationwide for the first time, and they’ve chosen a real heavyweight partner—Walmart. What comes in the package? Well, they’re dealing in...

AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

DOCS Faces Investor Legal Battle for Alleged Misconduct

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Roof Inspections: Richmond's Key to Home Longevity

Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...

AI-Designed Antivirals: A Brave New World

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

2GenPen & LordCap Team Up: Game-Changer in ABS?

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Ama La Vida's New Coaching: More Than a Financial Plan

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

Endava Faces Securities Fraud Lawsuit: Investor Implications

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...